Compounds > diazooxonorleucine

diazooxonorleucine and Arrhythmias, Cardiac

diazooxonorleucine has been researched along with Arrhythmias, Cardiac in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gao, F; Jiang, T; Jin, L; Li, C; Liu, B; Qin, X; Zheng, Q1
Bers, DM; Copeland, RJ; Dao, K; Despa, F; Erickson, JR; Ferguson, A; Han, G; Hart, GW; Pereira, L; Ripplinger, CM; Wang, L1

Other Studies

2 other study(ies) available for diazooxonorleucine and Arrhythmias, Cardiac

ArticleYear
Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity.
    Biochemical and biophysical research communications, 2021, 06-18, Volume: 558

    Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Diazooxonorleucine; Disease Models, Animal; Glycosylation; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Reperfusion Injury; Myocardium; Obesity; Protein Processing, Post-Translational; Rats

2021
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.
    Nature, 2013, Oct-17, Volume: 502, Issue:7471

    Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Benzylamines; Brain; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Complications; Diazooxonorleucine; Enzyme Activation; Glucose; Glycosylation; Humans; Hyperglycemia; Mice; Myocardium; Myocytes, Cardiac; Rats; Sarcoplasmic Reticulum; Sulfonamides

2013